Chemistry Service Platform - CRO in Medicinal Chemistry
 

 

 

 

 

 

Axon LigandsTM for Drug Discovery
Prime Source
High Value
High Quality
We make as Drug Standards
Serving diversified application fields
With expertise like CNS reagents

Brand-new like kinase inhibitors...

Hot Alert! NSC 348884, LY333531, Nilotinib, CT99021, SD-208, Sorafenib, Lapatinib,

BX-795, PF-477736, NNC 756, ...

First come first served!

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

Products    -  Axon Ligands TM   -  SEP-OCT 2008

BX 795 | PDK1 Inhibitor

CAS 702675-74-9  (Axon 1390)
 

PF 477736 | CHK1 Inhibitor

CAS 952021-60-2 (Axon 1379)

SD 208 | TGF-βR1 inhibitor

CAS 627536-09-8 (Axon 1387)

CT 99021 | GSK-3 inhibitor
CAS 252917-06-9 (Axon 1386)

Lapatinib | EGFR/ErbB-2 inhibitor

CAS 231277-92-2 (Axon 1395)

Nilotinib | BCR-ABL inhibitor

CAS 641571-10-0 (Axon 1396)

See featured Axon Ligands in Showcases 12, 3, 4, 5, 6... Next       <Back>

 

axonmedchem.com © 2007-2009

New Ligands

GDC-0941 | PI3K inhibitor

Atipamezole | α2 antagonist

Tiplaxtinin | PAI-1 inhibitor

SB 742457 | 5-HT6 antagonist

Varenicline | Nicotinic partial agonist

CP 690550 | JAK3 Inhibitor

MK 677 | GH secratagogue

PIK 90 | PI3K p110α inhibitor

CI-1040 | MEK1 inhibitor

STA 5326 | IL-12/IL-23 inhibitor

08AUG 08JUN 08MAY 08APR 08MAR 08FEB 08JAN 07DEC 07NOV 07OCT...

Antalarmin | CRF-1 antagonist

BEZ 235 | PI3K/mTOR inhibitor

B-HT 958 | α2 partial and D2 agonist

BIRB 796 | p38 MAPK inhibitor

CGS 21680 | A2A agonist

Chromanol 293B | K chan. blocker

Fenobam | mGlu5 antagonist

FK 866 | Anticancer agent

GR 103691 | D3 antagonist

GSK 269962A | ROCK1 inhibitor

GW 843682X | PLK inhibitor

GYKI 53655 | AMPA antagonist

Iodophenpropit | H3 antagonist

JNJ 10191584 | H4 antagonist

LY 294002 | PI3K Inhibitor

Myoseverin | Microtubule inhibitor

PD 123319 | AT-2 antagonist

PD 169316 | p38 MAPK Inhibitor

PF-00356231 | MMP-12 inhibitor

PIK 75 | PI3K p110α inhibitor

PNU 37883 | KATP channel blocker

RO 04-6790 | 5-HT6 antagonist

RO 25-6981 | NMDA antagonist

RO 28-1675 | Glucokinase activator

SB 202190 | p38 MAPK inhibitor

SB 203580 | p38 MAPK inhibitor

SB 216763 | GSK-3 inhibitor
SCH 79797 | PAR1 antagonist

ST 198 | DR D3 antagonist

ST 148 | DR D2 antagonist

U 92016A | 5-HT1A agonist